Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalap Duo vs Epiduo in Acne Vulgaris
NCT02716090Phase 3Withdrawn
- Sponsor
- Aché Laboratórios Farmacêuticos
- Primary completion
- Nov 2015
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of adapalene + benzoyl peroxide in acne vulgaris (2 arms), sponsored by Aché Laboratórios Farmacêuticos. Primary endpoint: Reduction of total acne lesion at 84 days. Status: withdrawn.
02
Drugs
adapalene + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02716090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02716090.